An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Phase 3
Completed
- Conditions
- Myocardial InfarctionMyocardial IschemiaAcute Coronary SyndromeUnstable Angina
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2014-09-17
- Target Recruit Count
- 15526
- Registration Number
- NCT00809965
A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery
Phase 2
Completed
- Conditions
- PainPostoperative Pain
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 480
- Registration Number
- NCT00806247
An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis
Phase 2
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2013-10-30
- Target Recruit Count
- 53
- Registration Number
- NCT00804687
An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2015-12-10
- Target Recruit Count
- 121
- Registration Number
- NCT00796120
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 35
- Registration Number
- NCT00796471
A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 4
- Registration Number
- NCT00796432
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 20
- Registration Number
- NCT00796276
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 5
- Registration Number
- NCT00796029
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 35
- Registration Number
- NCT00796640
A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 25
- Registration Number
- NCT00796081
© Copyright 2025. All Rights Reserved by MedPath